Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Diagnostic Cartridge Field Diagnostic System Market size was valued at USD 7.7 billion in 2024 and is set to exceed USD 14.34 billion by 2037, registering over 4.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diagnostic cartridge field diagnostic system is evaluated at USD 8.32 billion.
The uptrend of point-of-care diagnostics or near-patient testing to avail accurate, precise, and timely results will thrust the market growth.
Diagnostic field system refers to the detection of the amount of or an analyte in body fluids or tissue that affects the pathogenesis of any disease. It helps as a biological marker shown to indicate a predisposition to any disease. The field is gaining importance with the increasingly deteriorating lifestyle of the global population, diminishing immunity globally.
Diagnostic Cartridge Field Diagnostic System Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Prevalence of Chronic and Acute Diseases – Diseases such as diabetes, cardiac disorders, and cancer are now prevailing amongst people worldwide at a higher rate. This has emerged in the importance of a cartridge-based diagnostic market. According to the data from the World Health Organization (WHO), nearly 1.6 million deaths are caused by diabetes, and nearly 17.9 million deaths are caused by cardiovascular diseases worldwide every year.
- Increasing Importance of the Diagnostic Industry - The increasing demand for testing, quick results, and accurate diagnosis is leading to the adoption of technology and has further brightened the future of the smart diagnostic and monitoring medical device market. Moreover, augmenting awareness about preventive healthcare is poised to fuel market growth.
Challenges
- Challenge of Quality Control and Result Reporting - the improper quality check protocols and incomplete reporting of results hamper the growth of the market.
- Lack of Accuracy due to Test Error
- Slower Penetration
Diagnostic Cartridge Field Diagnostic System Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.9% |
|
Base Year Market Size (2024) |
USD 7.7 billion |
|
Forecast Year Market Size (2037) |
USD 14.34 billion |
|
Regional Scope |
|
Diagnostic Cartridge Field Diagnostic System Segmentation
Type (Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Electrolytes Testing)
The cardiac markers testing segment is slated to hold 40% share of the global diagnostic cartridge field diagnostic system market by 2037. The increasing cases of myocardial infarction (MI), commonly known as a heart attack can be predicted earlier with cardiac marker tests that identify blood chemicals associated with myocardial infarction. As per findings, in the United States, nearly at every 40 seconds someone suffers from a heart attack.
End-User (Specialty Clinics, Laboratory, Hospitals)
The hospital segment is anticipated to account for around 40% revenue share by 2037, owing to the rising advancements in diagnostic activities in the hospital setting. Increasing the use of handheld/ portable diagnostics devices is also propelling the market growth.
Further, healthcare practitioners also collect a blood sample from the patient and send this sample to a satellite lab for quick results due to the increasing volume of diagnoses that need to be performed in hospitals.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportDiagnostic Cartridge Field Diagnostic System Industry - Regional Synopsis
APAC Market Statistics
Asia Pacific industry is anticipated to hold largest revenue share of 35% by 2037. The increasing spread of disease in the region is resulting in several collaborations between corporates and multinational companies to uplift the overall diagnostic market. This is expected to pool investment in the diagnostic cartridge field diagnostic system market.
The cost-effective, hassle-free, and quality treatment options with superior diagnostic services available at low prices in countries such as India which is fast emerging as a medical tourism hub are also garnering more growth. India recorded a footfall of around 6.19 million foreign tourists in 2022, which was 4 times more compared with 1.52 million in 2021.
North American Market Forecast
North America diagnostic cartridge field diagnostic system market is estimated to register a share of about 25% till 2037. The rapid adoption of advanced medical technology in the region especially with the rising total spending in the healthcare sector is estimated to back the market expansion.
World Bank revealed that 16% of the total GDP of the North American region was spent on healthcare. Adding to it, the immense research by giant players to develop accurate testing tools is also estimated to boost market growth.
Companies dominating the Diagnostic Cartridge Field Diagnostic System Landscape
- Siemens Healthineers AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Arkray Inc.
- Becton, Dickinson, and Company
- Binx Health Limited
- Nova Biomedical Corporation
In the News
- ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc., and Shionogi announced the approval of the U.S. Food and Drug Administration (FDA) for Cabotegravir, an antiviral drug.
- Danaher Corporation announced the acquisition of Aldevron, to expand Danaher's life sciences segment.
Author Credits: Radhika Pawar
- Report ID: 3936
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
